Chronic Intestinal Amebiasis, Without Dysentery: Report of Two Cases.
Cummings RS.
Cal State J Med. 1913 Sep;11(9):364-5.
Chloroquine Therapy and G6PD Genotype.
Kane M.
2023 May 16. In: Pratt VM, Scott SA, Pirmohamed M, Esquivel B, Kattman BL, Malheiro AJ, editors. Medical Genetics Summaries [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2012–.
[Parasitic diarrhea].
Bourée P, Bisaro F.
Presse Med. 2007 Apr;36(4 Pt 2):706-16. doi: 10.1016/j.lpm.2006.12.028. Epub 2007 Mar 1.
Thoracic amebiasis.
Shamsuzzaman SM, Hashiguchi Y.
Clin Chest Med. 2002 Jun;23(2):479-92. doi: 10.1016/s0272-5231(01)00008-9.
The immunopathogenesis of Entamoeba histolytica.
Mortimer L, Chadee K.
Exp Parasitol. 2010 Nov;126(3):366-80. doi: 10.1016/j.exppara.2010.03.005. Epub 2010 Mar 19.
[Amebic meningoencephalitis].
Fukuma T.
Brain Nerve. 2009 Feb;61(2):115-21.
Chronic intestinal amebiasis; diagnosis and treatment.
MACKIE TT.
J Mich State Med Soc. 1952 Apr;51(4):478-82.
The future for vaccine development against Entamoeba histolytica.
Quach J, St-Pierre J, Chadee K.
Hum Vaccin Immunother. 2014;10(6):1514-21. doi: 10.4161/hv.27796. Epub 2014 Feb 6.
Chronic intestinal upsets due to amebiasis.
GROFF HD.
Del State Med J. 1948 Jun;20(6):116-8.
IL-17A contributes to reducing IFN-gamma/IL-4 ratio and persistence of Entamoeba histolytica during intestinal amebiasis.
Deloer S, Nakamura R, Kikuchi M, Moriyasu T, Kalenda YDJ, Mohammed ES, Senba M, Iwakura Y, Yoshida H, Hamano S.
Parasitol Int. 2017 Dec;66(6):817-823. doi: 10.1016/j.parint.2017.09.011. Epub 2017 Sep 18.
